Rejuvenate Biomed
PrivateLast Round
Series B
Oct 12, 2021
Total Funding Raised
$23.11M
Company Overview
Rejuvenate Biomed is a biotechnology company that develops combination drugs to treat age-related diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rejuvenate Biomed Comparables
Compare Rejuvenate Biomed with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Biophytis SA | 82% | |
| BioAge Labs | 76% | |
| Epirium Bio | 71% |
Rejuvenate Biomed Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 12, 2021 | ||||
| Series A | Mar 2, 2021 | ||||
| Grant | Aug 10, 2018 | ||||
| Accelerator | Mar 1, 2018 | ||||
| Seed | Nov 1, 2017 |
Key People
Founding team and executive leadership
Rejuvenate Biomed Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Vesalius Biocapital Partners | Series B |
| VLAIO | Series A, Grant |
| Johnson & Johnson Innovation - JLABS | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 745% MoM.
- Mar 2, 2021
Raised $3.84M led by Vesalius BioCapital.
Rejuvenate Biomed Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Rejuvenate Biomed's valuation, stock price, and market status.
Is Rejuvenate Biomed a public or private company?
Rejuvenate Biomed is a private company.
What is the current stock price of Rejuvenate Biomed?
Rejuvenate Biomed is a private company with no public stock price. No recent secondary market data is available.
How much is Rejuvenate Biomed worth (valuation)?
Valuation information for Rejuvenate Biomed is not publicly available.
Can I buy Rejuvenate Biomed stock?
Rejuvenate Biomed shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Rejuvenate Biomed's last funding round?
Rejuvenate Biomed's most recent funding round was Series B on October 12, 2021.
Who are the main investors in Rejuvenate Biomed?
Key investors in Rejuvenate Biomed include Vesalius Biocapital Partners.
Will Rejuvenate Biomed IPO soon?
No public IPO plans have been announced for Rejuvenate Biomed.
How can I track Rejuvenate Biomed secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Rejuvenate Biomed's secondary market activity and sign up for updates.